IssuerAnnouncementDetailsV2Portlet
Actions
AME Company for Medical Supplies Board invites its shareholders to attend the Extraordinary General Assembly Meeting the (First Meeting)
| Element List | Explanation |
|---|---|
| Introduction | The Board of Directors of AME Company for medical supplies is pleased to invite the honorable shareholders to participate in the Unordinary General Assembly meeting (the first and second meetings will be held one hour after the first), which is scheduled to be held, God willing, on Sunday, Dhu al-Qi’dah 27, 1446 AH, corresponding to May 25, 2025 AD, at 7:30 PM, via modern technology using the Tadawulati system. |
| City and Location of the General Assembly's Meeting | The company's headquarters is located in Jeddah, using modern technology (remotely) via the Tadawulati platform. |
| Hyperlink of the Meeting Location | Click Here |
| Date of the General Assembly's Meeting | 2025-05-25 Corresponding to 1446-11-27 |
| Time of the General Assembly’s Meeting | 19:30 |
| Methodology of Convening the General Assembly’s Meeting | Via modern technology means |
| Attendance Eligibility, Registration Eligibility, and Voting End | Every shareholder registered in the company's shareholders' register at the Securities Depository Center (Edaa) at the end of the trading session preceding the general assembly meeting has the right to attend the general assembly meeting. In accordance with the rules and regulations, shareholders have the right to discuss the topics included on the general assembly's agenda and to ask questions. |
| Quorum for Convening the General Assembly's Meeting | The validity of the general assembly meeting requires the attendance of a number of shareholders representing 25% of the capital. If the quorum is not met at this meeting, a second meeting will be held one hour after the end of the period specified for the first meeting. The second meeting will be valid regardless of the number of shares represented therein. |
| General Assembly Meeting Agenda | 1. Vote on amending Article No. (12) of the Company's Articles of Association regarding (Board Management) (attached) 2. Vote on amending Article Nineteen of the Company's Articles of Association regarding the quorum for Board of Directors meetings (attached) 3. Review and discuss the Board of Directors' report for the fiscal year ending December 31, 2024. (attached) 4. Review and discuss the financial statements for the fiscal year ending December 31, 2024. (attached) 5. Vote on the Company's auditor's report for the fiscal year ending December 31, 2024, after discussing it. (attached) 6. Vote on terminating the contract with the Company's current auditor, due to his having exhausted the maximum permitted statutory period, in accordance with Article Three of the Executive Regulations of the Companies Law issued by the Capital Market Authority regarding listed joint-stock companies. 7. Vote on the appointment of the Company's auditor from among the candidates based on the recommendation of the Audit Committee; To examine, review, and audit the financial statements for the second and third quarters and annual period of fiscal year 2025, and for the first, second, and third quarters and annual period of fiscal years 2026 and 2027, and to determine their fees. (Attached) 8. Vote to discharge the members of the Board of Directors from liability for the fiscal year 2024 9. Vote to terminate the current Board of Directors' term prematurely on July 30, 2025. 10. Voting on the Board of Directors' recommendation to distribute cash dividends in the amount of (14,000,000) (fourteen million) riyals to shareholders for the financial period ending on (12/31/2024), at a rate of (2) (two) riyals per share, representing (20%) of the capital. Eligibility shall be for shareholders who own shares at the end of trading on the day of the General Assembly meeting and are registered in the company's shareholders' register with the Securities Depository Center Company (Depository Center) at the end of the second trading day following the due date. Dividends will be disbursed starting on 06/11/2025 AD by transferring them to the accounts associated with the portfolios of eligible shareholders, effective from 06/11/2025 AD. 11. Voting on disbursing an amount of 660,000 riyals as remuneration to members of the Board of Directors for the fiscal year ending on December 31, 2024 AD. 12. Voting on amending the Board of Directors' Remuneration Policy (attached) 13. Voting on the Board of Directors' Nomination Standards and Procedures Policy (attached) |
| Proxy Form |  |
| The shareholder right in discussing the assembly agenda topics, asking questions, and exercising the voting right | Shareholders registered in Tadawulaty services will be able to vote remotely on the agenda items for the general assembly meeting, which will begin at 1:00 a.m. on Tuesday, Dhu al-Qi'dah 22, 1446 AH (corresponding to May 20, 2025 AD) and continue until the end of the general assembly meeting. Shareholders have the right to discuss the topics on the general assembly agenda and ask questions. Registration and voting in Tadawulaty services will be available to all shareholders via the following link: https://www.tadawulaty.com.sa |
| Details of the electronic voting on the Assembly’s agenda | Dear shareholders registered in Tadawulati services will be able to vote remotely on the items of the general assembly meeting agenda, which will start at (1:00) a.m. on Tuesday, Dhu al-Qi'dah 22, 1446 AH, corresponding to May 20, 2025 AD, until the end of the general assembly meeting, Registration and voting in Tadawulaty services will be available to all shareholders via the following link https://www.tadawulaty.com.sa |
| Method of Communication in Case of Any Enquiries | If you have any questions or inquiries, please contact the Shareholder Relations Department by phone at 0112765616 or by email at investor.relations@ame-ksa.net. Shareholders will be able to ask their questions during the general assembly. |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions